Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Severe Dengue
NCT05631405Recruiting
- Sponsor
- Chulalongkorn University
- Start
- Oct 2022
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in severe dengue (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Mortality at 28 days. Started Oct 2022; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
severe dengue
Beyond the preview
Go deeper on NCT05631405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05631405.